SIFTAXYS
LIVE

Serial Number

79423293

Owner

MAAT PHARMA

Attorney

Pina M. Campagna

Filing Date

Mar 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SIFTAXYS Trademark

Serial Number: 79423293 • Registration: 8112974

SIFTAXYS is a trademark filed by MAAT PHARMA on March 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MAAT PHARMA (12 trademarks)

70 avenue Tony Garnier

Entity Type: 99

Trademark Details

Filing Date

March 21, 2025

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication

Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 21, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 20, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2025 REPR